Iodide

Iodide

SCHEMBL3820106

C[n+]1ccn(-c2ccccc2)c1.[I-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
THRB P10828 2/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SLC22A2 O15244 1/20 0.37
SLC22A1 O15245 1/20 0.37
SLC22A3 O75751 1/20 0.37
SLC6A4 P31645 1/20 0.37
CHAT P28329 2/20 0.36
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
APOBEC3A P31941 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL666881 0.98 LMNA (0.41) LMNATHRBHPGDL3MBTL1TP53
Bromide SCHEMBL20531184 0.96 LMNA (0.40) LMNATHRBHPGDL3MBTL1TP53
Hydrochloric Acid SCHEMBL384462 0.96 LMNA (0.44) LMNATHRBHPGDL3MBTL1TP53
SCHEMBL384827 0.90 LMNA (0.38) LMNATHRBHPGDL3MBTL1TP53
Iodide SCHEMBL2535721 0.89 LMNA (0.33) LMNATHRBHPGDL3MBTL1TP53
Cyanate SCHEMBL665497 0.87 LMNA (0.36) LMNATHRBHPGDL3MBTL1TP53
Phosphoric Acid SCHEMBL20531178 0.87 LMNA (0.42) LMNATHRBHPGDL3MBTL1TP53
SCHEMBL12220256 0.87 LMNA (0.33) LMNATHRBHPGDL3MBTL1TP53
Iodide SCHEMBL31544627 0.86 CYP3A4 (0.33) LMNATHRBHPGDL3MBTL1CYP3A4
Iodide SCHEMBL31460541 0.86 MAPT (0.35) LMNATHRBHPGDL3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534485-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2026-01-27 US disclosed
US-20250127030-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-04-17 US disclosed
US-12171138-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-12-17 US disclosed
US-20240043460-A1 PHOSPHORESCENT C^C* PLATINUM(II) COMPLEXES WITH BORONIC LIGANDS AND THEIR USE AS EMITTERS IN OLEDS Technische Universität Dresden (DE) 2024-02-08 US disclosed
US-20220328774-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-10-13 US disclosed
CN-115160374-A Stable OLED materials and devices with improved stability 通用显示公司 2022-10-11 CN disclosed
US-11404650-B2 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-08-02 US disclosed
US-20220169670-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-06-02 US disclosed
US-11063229-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-07-13 US disclosed
CN-113024612-A Metal complexes comprising azaborine carbene ligands and their use in OLEDs 北京八亿时空液晶科技股份有限公司 2021-06-25 CN disclosed
US-7902374-B2 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2011-03-08 US disclosed
EP-1878053-B1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORP (US) 2009-08-26 EP disclosed
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2009-01-15 US disclosed
EP-1993728-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2008-11-26 EP disclosed
WO-2008054584-A1 IMPROVED STABILITY OLED MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2008-05-08 WO disclosed
EP-1878053-A1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY Universal Display Corporation (US) 2008-01-16 EP disclosed
WO-2007088093-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2007-08-09 WO disclosed
US-20070088167-A1 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION 2007-04-19 US disclosed
WO-2006121811-A1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORPORATION (US) 2006-11-16 WO disclosed
US-20060251923-A1 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES AP1M1, C1S, GPS1 LMNA 1542/4885THRB 3342/4885HPGD 3136/4885
US-20220328774-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBP2, EML4, OSBP LMNA 3221/4885THRB 3239/4885HPGD 3932/4885
US-11404650-B2 Stability OLED materials and devices OCIAD2, OCIAD1, OSBP2 LMNA 3178/4885THRB 3950/4885HPGD 2456/4885
US-12534485-B2 Organic electroluminescent materials and devices LBR, GLRB, GLRA3 LMNA 963/4885THRB 683/4885HPGD 4278/4885
US-20220169670-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ICOSLG, OCIAD1, OCIAD2 LMNA 1248/4885THRB 1525/4885HPGD 2603/4885
US-20250127030-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBP2, EML4, OSBP LMNA 3208/4885THRB 3193/4885HPGD 3911/4885
US-12171138-B2 Organic electroluminescent materials and devices OSBP2, EML4, OSBP LMNA 3221/4885THRB 3239/4885HPGD 3932/4885
US-20240043460-A1 PHOSPHORESCENT C^C* PLATINUM(II) COMPLEXES WITH BORONIC LIGANDS AND THEIR USE AS EMITTERS IN OLEDS ORC3, OCIAD2, CYCS LMNA 1060/4885THRB 3024/4885HPGD 3422/4885
US-11063229-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, ICOSLG LMNA 4418/4885THRB 4316/4885HPGD 1935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.